Label Statements and Perceived Health Benefits of Dietary Supplements
In this survey study, commonly used structure/function claims on supplement labels were often misinterpreted by consumers to imply a disease-specific benefit, contrary to their regulatory intent. Improved regulations for supplement labeling may be needed to minimize consumer misunderstanding.
Authors
- Ann Marie Návar (ORCID: https://orcid.org/0000-0002-6197-9860)
- Joanna N. Assadourian (ORCID: https://orcid.org/0000-0003-3086-7062)
- Eric David Peterson (ORCID: https://orcid.org/0000-0002-5415-4721)
Institutions
- Duke Medical Center (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-09-22
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.33118
- Citations
- 4
- Primary Topic
- Consumer Attitudes and Food Labeling
- Type
- article
- Field-Weighted Citation Impact
- 7.51
Funders
- Amgen
- Eli Lilly and Company
- AstraZeneca
- University of Texas Southwestern Medical Center
- Novo Nordisk
- Idorsia Pharmaceuticals
- Silence Therapeutics
- Esperion Therapeutics
- Janssen Pharmaceuticals